WINT - Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th | Benzinga
WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, President and Chief Executive Officer, will be participating in a panel discussion titled, "Cardiac Kids: Late-Stage Advancement for Cardiovascular Disorders," at the Lytham Partners Fall 2023 Investor Conference on Tuesday, October 17, 2023 at 10:30am ET. Windtree management will also be participating in virtual 1x1 meetings with investors at the event.
The panel discussion will include Windtree's progress on its lead pipeline candidate istaroxime for the treatment of cardiogenic shock. The ...